Concepts · Definition

Topical bioavailability

What is Topical bioavailability?

Topical bioavailability is the fraction of an applied active that reaches its target site in the skin in active form, and how fast it gets there. It is often low. In a classic radiolabel study only about 1% of hydrocortisone applied to the forearm was absorbed. The vehicle is therefore a major factor in therapeutic outcome.

Also searched as: dermal bioavailability · skin bioavailability

Related terms

← All glossary terms · Understand the Technology


Methodology

Content is written from primary sources: granted US patent text, peer-reviewed journals indexed in PubMed or Crossref, and regulator publications. Numerical specifications are quoted exactly as reported in the cited source. Where data are illustrative models rather than measurements, the figure says so.

Conflict of interest & scope

Cetosomes.com is operated in association with parties that manufacture and dispense Cetosome®-based formulations. This site explains vehicle and delivery biophysics; it does not diagnose, treat or prescribe. Clinical decisions belong to a qualified dermatologist or physician. Research articles in the Journal carry no product or brand references.

In your routine or your clinic

Explore Cetosome® formulations

Cetosome® vehicles are dispensed through dermatology, not mass retail. The direct way to bring the technology into your routine or practice is Monoskin, the dermatological range built on the platform.

For your skin: choose a need

For your clinic

Stocking or prescribing Cetosome® formulations? Reach the clinic team, or ask our formulation desk for the literature dossier.

Opens monoskin.com in a new tab. Diagnosis and the choice of active belong to your dermatologist.